111 Inc
YI7.395USD
-0.055-0.74%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
374.74MMarket Cap
LossP/E TTM
More Details of 111 Inc Company
111 Inc is an investment holding company primarily engaged in the operation of integrated online and offline healthcare platform. The Company mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The Company also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The Company mainly conducts its business in the domestic market.
111 Inc Info
Ticker SymbolYI
Company name111 Inc
IPO dateSep 12, 2018
CEOLiu (Junling)
Number of employees1238
Security typeDepository Receipt
Fiscal year-endSep 12
Address3-4/F, No.295 Zuchongzhi Road
CitySHANGHAI
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryChina
Postal code201203
Phone862120536666
Websitehttp://corporate.111.com.cn/
Ticker SymbolYI
IPO dateSep 12, 2018
CEOLiu (Junling)
Company Executives of 111 Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Gang Yu, Ph.D.
Dr. Gang Yu, Ph.D.
Executive Co-Chairman of the Board, Co-Founder
Executive Co-Chairman of the Board, Co-Founder
--
--
Mr. Junling Liu
Mr. Junling Liu
Co-Chairman of the Board, Chief Executive Officer, Co-Founder
Co-Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Mr. Nee Chuan Teo, CPA
Mr. Nee Chuan Teo, CPA
Independent Director
Independent Director
--
--
Mr. Jian (David) Sun
Mr. Jian (David) Sun
Independent Director
Independent Director
--
--
Mr. Jun Luo
Mr. Jun Luo
Independent Director
Independent Director
--
--
Mr. Yang (Luke) Chen
Mr. Yang (Luke) Chen
Director
Director
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Gang Yu, Ph.D.
Dr. Gang Yu, Ph.D.
Executive Co-Chairman of the Board, Co-Founder
Executive Co-Chairman of the Board, Co-Founder
--
--
Mr. Junling Liu
Mr. Junling Liu
Co-Chairman of the Board, Chief Executive Officer, Co-Founder
Co-Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Mr. Nee Chuan Teo, CPA
Mr. Nee Chuan Teo, CPA
Independent Director
Independent Director
--
--
Mr. Jian (David) Sun
Mr. Jian (David) Sun
Independent Director
Independent Director
--
--
Mr. Jun Luo
Mr. Jun Luo
Independent Director
Independent Director
--
--
Mr. Yang (Luke) Chen
Mr. Yang (Luke) Chen
Director
Director
--
--
Revenue Breakdown
Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Product Revenues
2.98B
99.44%
Service Revenues
16.89M
0.56%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Product Revenues
2.98B
99.44%
Service Revenues
16.89M
0.56%
Shareholding Stats
Updated: Fri, Jan 30
Updated: Fri, Jan 30
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
First Pharmacia International
8.57%
Susquehanna International Group, LLP
0.59%
Renaissance Technologies LLC
0.26%
Morgan Stanley & Co. LLC
0.10%
Serenus Wealth Advisors, LLC
0.09%
Other
90.39%
Shareholders
Shareholders
Proportion
First Pharmacia International
8.57%
Susquehanna International Group, LLP
0.59%
Renaissance Technologies LLC
0.26%
Morgan Stanley & Co. LLC
0.10%
Serenus Wealth Advisors, LLC
0.09%
Other
90.39%
Shareholder Types
Shareholders
Proportion
Corporation
8.57%
Investment Advisor
0.68%
Hedge Fund
0.26%
Research Firm
0.10%
Investment Advisor/Hedge Fund
0.05%
Other
90.33%
Institutional Shareholding
Updated: Wed, Jan 21
Updated: Wed, Jan 21
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q4
25
52.21K
6.89%
--
2025Q4
37
55.41K
1.09%
-397.88K
2025Q3
42
1.21M
23.79%
-403.88K
2025Q2
48
1.99M
39.33%
-416.92K
2025Q1
49
2.00M
39.53%
-387.91K
2024Q4
51
2.26M
44.72%
+133.67K
2024Q3
43
1.99M
39.36%
-280.22K
2024Q2
45
2.17M
42.88%
-87.92K
2024Q1
52
2.15M
42.65%
-125.45K
2023Q4
54
2.16M
44.89%
-28.04K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
First Pharmacia International
434.53K
8.57%
--
--
Mar 31, 2025
Susquehanna International Group, LLP
29.91K
0.59%
+15.14K
+102.54%
Sep 30, 2025
Renaissance Technologies LLC
13.01K
0.26%
--
--
Sep 30, 2025
Morgan Stanley & Co. LLC
5.14K
0.1%
--
--
Sep 30, 2025
Geode Capital Management, L.L.C.
2.44K
0.05%
--
--
Nov 30, 2025
UBS Financial Services, Inc.
1.45K
0.03%
-4.67K
-76.32%
Sep 30, 2025
SBI Securities Co., Ltd.
184.00
0%
-40.00
-17.86%
Sep 30, 2025
J.P. Morgan Securities LLC
23.00
0%
+15.00
+187.50%
Sep 30, 2025
Parametric Portfolio Associates LLC
27.00
0%
--
--
Sep 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
SPDR S&P Emerging Markets Small Cap ETF
0%
SPDR Portfolio Emerging Markets ETF
0%
SPDR S&P Emerging Asia Pacific ETF
0%
SPDR S&P Emerging Markets Small Cap ETF
Proportion0%
SPDR Portfolio Emerging Markets ETF
Proportion0%
SPDR S&P Emerging Asia Pacific ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
Jan 03, 2025
Merger
10→1
Jan 03, 2025
Merger
10→1
Jan 03, 2025
Merger
10→1
Jan 03, 2025
Merger
10→1
Date
Ex-dividend Date
Type
Ratio
Jan 03, 2025
Merger
10→1
Jan 03, 2025
Merger
10→1
Jan 03, 2025
Merger
10→1
Jan 03, 2025
Merger
10→1
